Respiratory Syncytial Virus (RSV) Vaccinations Administered in Pharmacies and Physician Medical Offices (IQVIA), Adults 60 years and older

At a glance

  • The projected estimates of RSV vaccinations administered at pharmacies are based on IQVIA LRx product and vaccinations administered in retail pharmacies.
  • The projected estimates of RSV vaccinations administered at physicians' medical offices are based on IQVIA's Dx product.

Adults 60+ RSV Vaccinations Administered in Pharmacies and Physician Medical Offices*

  • The projected pharmacy estimates are based on IQVIA†,‡ LRx product and vaccinations administered in retail pharmacies (including chain, mass merchandise, food stores, and independent pharmacies). Using the raw number of doses administered at a sample of retail pharmacies, IQVIA uses a proprietary projection methodology to estimate the projected number of vaccinations administered at all retail pharmacies For the 2023-24 season, projected estimates are based on a sample of 40,469 pharmacies.^ The estimates include RSV vaccinations that were billed to insurers (i.e. claims) or paid by cash. Projected pharmacy estimates are updated each week for the prior 13 weeks. Evaluations are underway to determine average time-lag for claims and data processing for RSV vaccinations; for comparison purposes, initial evaluation of IQVIA flu vaccination estimates is available and indicates that the reported number of doses administered for a particular week increased over the next few weeks.
  • The projected physicians' medical offices estimates are based on IQVIA's Dx product. Using the raw number of doses administered at the offices of a sample of physicians from American Medical Association's (AMA) proprietary list, IQVIA uses a proprietary projection methodology to estimate the projected number of vaccinations administered in medical offices of all physicians from AMA's list. For the 2023-24 season, projected estimates were based on a sample of 2,866 AMA physicians. The number of AMA primary care physicians in the U.S. is 258,350.± The estimates include RSV vaccinations that are claims-based only, and estimates are expected to increase over time for a given time period as claims are processed and adjudicated. Projected estimates are updated monthly and do not mature until about two months. This results in an increase or decrease in the initial or subsequent estimates for a given week. Evaluations are underway to determine average time-lag for claims and data processing for RSV vaccinations; for comparison purposes, initial evaluation of IQVIA flu vaccination estimates is available and indicates that the reported number of doses administered for a particular week increased over the next few weeks.
  • Vaccinations administered in workplaces, community locations, long-term care settings, and other medical settings such as public health clinics are not represented in these data.
  • Figure 4. Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Retail Pharmacies and Physicians' Medical Offices, Adults 60 years and older, United States, Data Source(s): IQVIA Pharmacy and Physician Medical Office Claims. Data are current through April 27, 2024.

*National estimates for retail pharmacies and physicians’ medical offices include vaccinations administered in 50 states and the District of Columbia. National estimates for medical office vaccinations do not include doses where geographic information (i.e. which state the dose was administered in) was missing. Pharmacy data are through Friday of each week and medical office data are through Saturday of each week.

†King, L. M., Bartoces, M., Fleming-Dutra, K. E., et al. (2020). Changes in US outpatient antibiotic prescriptions from 2011–2016. Clinical Infectious Diseases, 70(3), 370-377.

‡McLaughlin, J. M., Swerdlow, D. L., Khan, F., et al. (2019). Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States. Human vaccines & immunotherapeutics, 15(4), 841-849.

^The total number of retail pharmacies in the U.S. was estimated at 57,000 in 2022. https://www.mckinsey.com/industries/healthcare/our-insights/meeting-changing-consumer-needs-the-us-retail-pharmacy-of-the-future. Accessed on 02.22.2024.

±Total number of physicians of all specialties is 989,320; of these, primary care physicians include Internal Medicine (IM), Family Medicine/General Practice, IM/Pediatrics, and Geriatrics. 2023 U.S. Physician Workforce Data Dashboard | AAMC. Accessed on 02.22.2024.

*National estimates for retail pharmacies and physicians' medical offices include vaccinations administered in 50 states and the District of Columbia. National estimates for medical office vaccinations do not include doses where geographic information (i.e. which state the dose was administered in) was missing. Pharmacy data are through Friday of each week and medical office data are through Saturday of each week.

King, L. M., Bartoces, M., Fleming-Dutra, K. E., et al. (2020). Changes in US outpatient antibiotic prescriptions from 2011–2016. Clinical Infectious Diseases, 70(3), 370-377.

McLaughlin, J. M., Swerdlow, D. L., Khan, F., et al. (2019). Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States. Human vaccines & immunotherapeutics, 15(4), 841-849.

^The total number of retail pharmacies in the U.S. was estimated at 57,000 in 2022. https://www.mckinsey.com/industries/healthcare/our-insights/meeting-changing-consumer-needs-the-us-retail-pharmacy-of-the-future. Accessed on 02.22.2024.

±Total number of physicians of all specialties is 989,320; of these, primary care physicians include Internal Medicine (IM), Family Medicine/General Practice, IM/Pediatrics, and Geriatrics. 2023 U.S. Physician Workforce Data Dashboard | AAMC. Accessed on 02.22.2024.